Navigating the bleeding risk dilemma in patients with atrial fibrillation on therapy with direct-acting oral anticoagulants: Comparing the HAS-BLED vs. DOAC Score

MeSH terms

• Administration, Oral
• Aged
• Anticoagulants* / administration & dosage
• Anticoagulants* / adverse effects
• Anticoagulants* / therapeutic use
• Atrial Fibrillation* / complications
• Atrial Fibrillation* / drug therapy
• Factor Xa Inhibitors / administration & dosage
• Factor Xa Inhibitors / adverse effects
• Factor Xa Inhibitors / therapeutic use
• Hemorrhage* / chemically induced
• Humans
• Risk Assessment
• Stroke / etiology
• Stroke / prevention & control